 Anticancer Activity of Fadraciclib Monotherapy in Patients with MCL1 Amplified Solid Tumors Appointment of Mark Kirschbaum, M.D. as Chief Medical Officer 7 Million Strategic Investment by Fundamental Investor Acorn Bioventures 